Studies of the role of the peroxisome proliferators-activated receptor plays in lipotoxic cardiomyopathy will provide new strategies to prevent and cure lipotoxic cardiomyopathy.

• 研究过氧化物酶体增殖剂活化受体在脂毒性心肌病中的作用,可以为预防和治疗脂毒性心肌病提供新思路。